Tonix Pharma (TNXP) Tops Q1 EPS by 284c

Tonix Pharma (NASDAQ: TNXP) reported Q1 EPS of $2.84. Revenue for the quarter came in at $2.43 million versus the consensus estimate of $4.2 million.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Accuray (ARAY) Tops Q4 EPS by 1c
• Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts